xAnts

COVID-19 Breakthrough: New Study Highlights JAK Inhibitors as Top Treatment for Severe Cases

Reuters

Cape Town, South Africa – A groundbreaking study published in The Lancet Respiratory Medicine has identified a promising new treatment approach for severe COVID-19. Researchers are recommending that Janus kinase (JAK) inhibitors, a class of drugs kn ...Read more